|  | Placebo (n = 31) | CPC mouthwash (n = 31) | On-demand ACD mouthwash (n = 28) | |||
---|---|---|---|---|---|---|---|
Male, n (%) | 14 | (45.2) | 23 | (74.2) | 14 | (50.0) | |
Median (IQR) age (years) | 30.1 | (23.1–47.8) | 38.4 | (25.5–47.4) | 33.9 | (27.1–40.5) | |
Median (IQR) body mass index (kg/m2) | 22.5 | (21.0–23.7) | 22.3 | (19.6–25.2) | 22.2 | (20.5–24.7) | |
Smoking history, n (%) | Â | Â | Â | Â | Â | Â | |
 | Non-smokers | 20 | (64.5) | 21 | (67.7) | 22 | (78.6) |
 | Former smokers | 8 | (25.8) | 6 | (19.4) | 1 | (3.6) |
 | Current smokers | 3 | (9.7) | 4 | (12.9) | 5 | (17.9) |
Comorbidity (yes), n (%) | 5 | (16.1) | 8 | (25.8) | 6 | (21.4) | |
COVID-19 vaccination status, n (%) | Â | Â | Â | Â | Â | Â | |
 | None | 1 | (3.2) | 0 | (0.0) | 1 | (3.6) |
 | One dose | 0 | (0.0) | 1 | (3.2) | 0 | (0.0) |
 | Two doses | 10 | (32.3) | 9 | (29.0) | 13 | (46.4) |
 | Three doses | 14 | (45.2) | 16 | (51.6) | 13 | (46.4) |
 | Four or more doses | 6 | (19.4) | 5 | (16.1) | 1 | (3.6) |
Median (IQR) days from onset to diagnosis | 2 | (1–2) | 2 | (1–2) | 2 | (1–2) | |
Median (IQR) pulse oximetry (SpO2) | 99 | (98–99) | 98 | (98–99) | 98 | (98–99) | |
Median (IQR) salivary Ct value | 38.0 | (36.5–39.8) | 38.6 | (35.3–41.2) | 35.2 | (32.6–38.1) |